Papers
10
Total Citations
653
H-Index
7
About
Anton Simeonov is a pioneering researcher at the intersection of high-throughput screening technology, toxicology, and stem cell biology. Best known for his foundational contributions to robotic automation in biomedical research, Simeonov has helped transform how scientists evaluate chemical safety and develop therapeutic leads at scale. His landmark 2013 paper on the Tox21 robotic platform (255 citations) established a new paradigm for assessing environmental chemical toxicity using automated, high-throughput in vitro methods — dramatically reducing reliance on animal testing. His 2008 work on quantitative high-throughput screening infrastructure (157 citations) became a touchstone reference for academic institutions adopting large-scale screening programs. More recently, Simeonov has extended robotic automation into regenerative medicine, developing scalable systems for manufacturing and differentiating human induced pluripotent stem cells (hiPSCs) into clinically relevant cell types, including sensory neurons for pain research and hypothalamic arcuate neurons for studying metabolic disorders. His 2023 review on advancing in vitro toxicology further cements his role as a thought leader shaping the future of predictive safety science. Across disciplines, Simeonov's work consistently bridges engineering precision with biological discovery, making complex systems more reproducible, accessible, and translatable for researchers worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2A Robotic Platform for Quantitative High-Throughput Screening157 citations · 2008
- 3
- 4
- 5
- 6Scalable generation of sensory neurons from human pluripotent stem cells48 citations · 2023
- 7
- 8
- 9
- 10